Page last updated: 2024-09-03

gefitinib and Alopecia

gefitinib has been researched along with Alopecia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, PC; Chu, CY; Shih, YH	1
Donovan, JC; Ghazarian, DM; Shaw, JC	1
Fujii, N; Fujimoto, N; Kato, T; Nagao, T; Nakanishi, G; Tanaka, T; Toda, N	1
Burt, PA; Lee, LW	1
Graves, JE; Heffernan, MP; Jones, BF; Lind, AC	1

Reviews

1 review(s) available for gefitinib and Alopecia

Article	Year
Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors. Dermatology (Basel, Switzerland), 2012, Volume: 225, Issue:1 Topics: Aged; Alopecia; Antineoplastic Agents; Asian People; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Scalp Dermatoses	2012

Article

Year

Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors.

Dermatology (Basel, Switzerland), 2012, Volume: 225, Issue:1

Topics: Aged; Alopecia; Antineoplastic Agents; Asian People; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Scalp Dermatoses

2012

Other Studies

4 other study(ies) available for gefitinib and Alopecia

Article	Year
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-10, Volume: 31, Issue:20 Topics: Aged; Alopecia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cicatrix; Female; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Quinazolines; Risk Assessment; Severity of Illness Index	2013
Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib. Archives of dermatology, 2008, Volume: 144, Issue:11 Topics: Aged; Alopecia; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cicatrix; Disease Progression; ErbB Receptors; Fatal Outcome; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Quinazolines; Risk Assessment	2008
Hair growth after gefitinib treatment. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:6 Topics: Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; ErbB Receptors; Gefitinib; Hair; Humans; Hypertrichosis; Lung Neoplasms; Male; Middle Aged; Quinazolines	2005
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:2 Topics: Aged; Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Gefitinib; Humans; Inflammation; Lung Neoplasms; Quinazolines; Time Factors	2006